Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FE814
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,092
Award facts
- Contract value 100% obligated
- $31,092.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $31,092.00 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, under a firm fixed-price contract type with an ultimate completion date of December 17, 2025. This non-competitive delivery order, issued from the Pharmaceutical Pharmacovigilance Division, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain.
This delivery order falls within the scope of AmerisourceBergen's comprehensive $999,999,999.00 prime IDC with DLA Troop Support Medical (designated SPE2DX, running through December 2026), which enables the company to supply a broad range of pharmaceutical products and medical supplies globally to support military healthcare programs. The company's federal contract portfolio demonstrates extensive capability in delivering brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical devices across multiple therapeutic domains. The DLA is currently planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue serving Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles.
Quick answers
Who was awarded contract SPE2DU26FE814?
SPE2DU26FE814 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DU26FE814 worth?
The government has obligated $31,092 on SPE2DU26FE814.
Is contract SPE2DU26FE814 an order under another contract?
Yes. SPE2DU26FE814 is a delivery order under SPE2DU25D5117, an indefinite delivery contract.
Was contract SPE2DU26FE814 competed?
The extent of competition for SPE2DU26FE814 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award